IWMPD
AERI

Integrated Wealth Management (Palm Desert)’s Aerie Pharmaceuticals AERI Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-500
Closed -$19K – 1096
2016
Q3 		$19K Hold
500
– – 0.01% 620
2016
Q2 		$9K Buy
+500
New +$8.09K ﹤0.01% 797

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s AERI Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Aerie Pharmaceuticals (AERI) in Q4 2016, closing a stake of 500 shares — an estimated $19K sold.

Integrated Wealth Management (Palm Desert) first reported a position in AERI in Q2 2016 and held it in 2 quarters. The position peaked at $19K in Q3 2016. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Aerie Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 500 Aerie Pharmaceuticals shares in Q4 2016, an estimated $19K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Aerie Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Integrated Wealth Management (Palm Desert)'s Aerie Pharmaceuticals position peaked at $19K in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.